Yahoo Malaysia Web Search

Search results

  1. www.novartis.com › news › news-archiveNews Archive | Novartis

    May 31, 2024 · About. Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease.

  2. www.novartis.com › pk-enNovartis

    Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives. Research & Development We are exploring possibilities to cure disease, intervene earlier in chronic illnesses, and find ways to improve and extend people’s lives.

  3. www.novartis.com › news › our-next-eraOur next era | Novartis

    Dec 4, 2023 · Novartis poised to expand impact on human health as it begins next era. Dec 04, 2023. It’s a historic moment for Novartis. Following the Sandoz spin-off in October and capping a multi-year transformation, we’ve entered our next era as an innovative medicines company. In this new chapter, our commitment to our purpose of reimagining medicine ...

  4. Oct 4, 2023 · Novartis is providing the information in this media update as of this date and does not undertake any obligation to update any forward-looking statements contained in this media update as a result of new information, future events or otherwise. About Novartis Novartis is a focused innovative medicines company.

  5. Novartis has a significant presence in India, with a robust commitment to R&D towards expanding access to innovative medicines to patients. In India, Novartis has had a significant footprint since 1947, committed to drug development, manufacturing, commercial and social business services. We have two legal entities namely, Novartis Healthcare ...

  6. Why Novartis (NVS) is a Top Value Stock for the Long-Term Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of ...

  7. In 2019, Novartis invested USD 3.9 billion in US-based research and development (R&D), representing more than 41% of our global R&D spend of USD 9.4 billion. Learn more. Value and Pricing. At Novartis, we are pushing the boundaries of science to reimagine medicine and bring the benefits of transformative innovation to patients everywhere. Learn ...

  1. People also search for